Literature DB >> 7882558

IL-1 beta and IL-6 stimulate the production of platelet-activating factor (PAF) by cultured rabbit synovial cells.

S Gutierrez1, I Palacios, J Egido, P Zarco, R Miguelez, E González, G Herrero-Beaumont.   

Abstract

The aim of this study was to determine whether synovial cells are capable of producing PAF in the presence of cytokines such as IL-1 beta and IL-6 and other stimuli. Synovial cells were obtained from joints of healthy rabbits. PAF production was assayed by measurement of serotonin release in rabbit platelets and the incorporation of 3H-acetate into PAF. Synovial cells produced PAF after 5 min of incubation with ionophore A23187, reaching the maximal amount at 15 min (4.3 +/- 0.7 x 10(-3) pmol of PAF/mg protein, P < 0.005, n = 4), and declining afterwards. The treatment of synoviocytes with IL-1 beta and IL-6 induced synthesis of PAF after 5 min of stimulation, reaching the greatest production at 15 min with IL-6 and 30 min with IL-1 beta (3.6 +/- 1.1 x 10(-3) and 3.3 +/- 1.2 pmol of PAF/mg protein, respectively, P < 0.05, n = 4). The incubation of the cells with PMSF, an inhibitor of acetylhydrolase, before the addition of the stimuli, increased the incorporation rate of 3H-acetate, suggesting a rapid degradation of PAF by synoviocytes. These results demonstrate that synovial cells can produce PAF after stimulation with agonists, such as ionophore, and cytokines. Thus, PAF, acting alone or with other mediators, could amplify the inflammatory joint reaction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7882558      PMCID: PMC1534206          DOI: 10.1111/j.1365-2249.1995.tb05559.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Human synovial-cell culture use of a new method in a study of rheumatoid arthritis.

Authors:  J R FRASER; K J CATT
Journal:  Lancet       Date:  1961-12-30       Impact factor: 79.321

3.  Inhibition by angiotensin converting enzyme inhibitors of endothelin secretion from cultured human endothelial cells.

Authors:  H Yoshida; M Nakamura
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

4.  Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases.

Authors:  A Dulioust; P Hilliquin; C J Menkes; J Benveniste; B Arnoux
Journal:  Scand J Rheumatol       Date:  1992       Impact factor: 3.641

5.  Structural analysis of purified platelet-activating factor by lipases.

Authors:  J Benveniste; J P Le Couedic; J Polonsky; M Tence
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

Review 6.  Platelet-activating factor: receptors and signal transduction.

Authors:  W Chao; M S Olson
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

7.  Improved high-performance liquid chromatographic method for isolation of platelet-activating factor from other phospholipids.

Authors:  M L Blank; F Snyder
Journal:  J Chromatogr       Date:  1983-04-08

8.  Light microscopic characterization of the fibroblast-like synovial intimal cell (synoviocyte).

Authors:  L S Wilkinson; A A Pitsillides; J G Worrall; J C Edwards
Journal:  Arthritis Rheum       Date:  1992-10

9.  Involvement of platelet-activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits.

Authors:  P Zarco; C Maestre; G Herrero-Beaumont; E González; R Garcia-Hoyo; F J Navarro; P Braquet; J Egido
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

10.  Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response.

Authors:  P M Henson
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

View more
  3 in total

1.  PAF, a potent proinflammatory mediator, looking for its role in the pathogenesis of joint damage.

Authors:  G Herrero-Beaumont; J Egido
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

Review 2.  Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

Authors:  W L Biffl; E E Moore; F A Moore; V M Peterson
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

3.  Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells.

Authors:  I Palacios; M J Lopez-Armada; P Hernandez; O Sanchez-Pernaute; S Gutierrez; R Miguelez; J Martinez; J Egido; G Herrero-Beaumont
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.